Castle Biosciences Inc (CSTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,582 | -14,522 | -24,158 | -21,826 | -21,325 |
| Depreciation Amortization | 7,153 | 3,475 | 36,552 | 33,483 | 30,572 |
| Income taxes - deferred | -13 | -10 | -6,228 | -5,321 | -5,437 |
| Accounts receivable | -4,742 | 1,075 | 6,876 | 604 | -1,307 |
| Accounts payable and accrued liabilities | 886 | 3,193 | 3,078 | 3,095 | 1,689 |
| Other Working Capital | -18,226 | -19,358 | 13,601 | -368 | -11,871 |
| Other Operating Activity | 24,596 | 4,018 | 34,626 | 27,749 | 22,464 |
| Operating Cash Flow | $-6,928 | $-22,129 | $64,347 | $37,416 | $14,785 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -29,522 | -16,036 | 486 | -16,106 | -12,532 |
| PPE Investments | -21,092 | -12,448 | -35,976 | -28,797 | -13,982 |
| Net Acquisitions | N/A | N/A | -18,727 | -18,726 | -18,726 |
| Purchase Of Investment | 0 | 0 | -5,569 | -5,569 | -5,569 |
| Sale Of Investment | 8,848 | 2,681 | 1,533 | N/A | 0 |
| Other Investing Activity | 0 | 0 | -2,114 | 0 | 0 |
| Investing Cash Flow | $-41,766 | $-25,803 | $-60,367 | $-69,198 | $-50,809 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -48 | -24 | -115 | -88 | -57 |
| Common Stock Issued | 2,520 | 1,589 | 4,622 | 1,816 | 1,519 |
| Other Financing Activity | -8,391 | -6,598 | -11,467 | -4,099 | -2,914 |
| Financing Cash Flow | $-5,919 | $-5,033 | $-6,960 | $-2,371 | $-1,452 |
| Beginning Cash Position | 116,729 | 116,729 | 119,709 | 119,709 | 119,709 |
| End Cash Position | 62,116 | 63,764 | 116,729 | 85,556 | 82,233 |
| Net Cash Flow | $-54,613 | $-52,965 | $-2,980 | $-34,153 | $-37,476 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,928 | -22,129 | 64,347 | 37,416 | 14,785 |
| Capital Expenditure | -21,105 | -12,455 | -36,021 | -28,837 | -14,003 |
| Free Cash Flow | -28,033 | -34,584 | 28,326 | 8,579 | 782 |